AstraZeneca Wins Seroquel Suit, But Court Punts Warning Issue

Law360, New York (July 11, 2012, 3:43 PM EDT) -- A Washington federal judge ruled Monday that AstraZeneca LP was not responsible for warning a Seroquel user that the antipsychotic could cause a neurological disorder, though he declined to address whether overpromotion of a drug imposes a duty to warn on its manufacturer.

Plaintiff Kay Patteson had argued to U.S. District Judge James E. Boasberg that the learned intermediary doctrine, which shields drugmakers from failure-to-warn claims if they apprised a plaintiff's physician of the product's risks, should not apply to AstraZeneca. Patteson relied on the so-called...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

PATTESON et al v. ASTRAZENECA, LP et al


Case Number

1:10-cv-01760

Court

District Of Columbia

Nature of Suit

Personal Inj. Prod. Liability

Judge

James E. Boasberg

Date Filed

October 18, 2010

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.